Theriva Biologics Inc Com Par $.001 Made Big Gain
Wed, Mar 20, 2024 at 07:30 PM
Theriva Biologics Inc Com Par $.001 (TOVX:NYSEMKT) rocketted at $0.62, representing a gain of 40%. On Wed, Mar 20, 2024, TOVX:NYSEMKT touched a New 2-Week High of $0.62. The stock appeared on our News Catalysts scanner on Tue, Mar 19, 2024 at 10:04 AM in the 'EARNINGS' category. From Wed, Mar 06, 2024, the stock recorded 50.00% Up Days and 27.27% Green Days
About Theriva Biologics Inc Com Par $.001 (TOVX:NYSEMKT)
Synthetic Biologics is a late-stage biotechnology company focused on developing gut microbiome therapeutics.
Top 10 Gainers:
- Republic First Bancorp, Inc. (FRBK:NASDAQ), 280.95%
- XTL Biopharmaceuticals Ltd. (XTLB:NASDAQ), 131.07%
- SRAX, Inc. (SRAX:NASDAQ), 90%
- Etao International Co. Ltd. (ETAO:NASDAQ), 88.81%
- TruGolf Inc Cl A (TRUG:NASDAQ), 64.35%
- Cazoo Group Ltd Class A (CZOO:NYSE), 63.85%
- Anghami Inc. (ANGH:NASDAQ), 59%
- Brainstorm Cell Therapeutics Inc. (BCLI:NASDAQ), 42.54%
- AEye Inc. (LIDR:NASDAQ), 41.9%
- Theriva Biologics Inc Com Par $.001 (TOVX:NYSEMKT), 39.95%